Skip to content
Recall Observatory FDA recall evidence

Drug product

Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) 100 tablets per bottle, NDC 13107-282-01 b) 500 tablets per bottle, NDC 13107-282-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

D-0491-2024

April 24, 2024

Class II

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 94500
Status
Ongoing
Classification
Class II
Quantity
6696 bottles
Official record key
drug-enforcement:D-0491-2024

Official wording

Reason: Discoloration: Dotted and yellow spots on tablets

Code information: Lot #s: a) CZA124001B, CZA124002B, CZA124003B, Exp. 12/31/2025; b) CZA124001A, CZA124003A, Exp. 12/31/2025.

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Discoloration: Dotted and yellow spots on tablets